Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes

Toxicology and Applied Pharmacology

Volumn 271, Issue 2, 2013, Pages 196-205

  Rovetta, Francesca ^a,b   Stacchiotti, Alessandra ^a   Faggi, Fiorella ^a,b   Catalani, Simona ^a   Apostoli, Pietro ^a   Fanzani, Alessandro ^a,b   Aleo, Maria Francesca ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Interuniversity Institute of Myology IIM   (Italy)

Author keywords

Atrophy; C2C12 myotubes; Cell stress; Cobalt; Necroptosis; Skeletal muscle

Indexed keywords

CASPASE 3; CASPASE 9; COBALT; COBALT CHLORIDE; DEATH RECEPTOR; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN 27; I KAPPA B; NECROSTATIN 1; PROPIDIUM IODIDE; PROTEASOME; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; DOWN REGULATION; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; MUSCLE ATROPHY; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ATROPHY; C2C12 MYOTUBES; CELL STRESS; COBALT; NECROPTOSIS; SKELETAL MUSCLE;

ATROPHY; AUTOPHAGY; BLOTTING, WESTERN; CELL DEATH; CELL LINE; COBALT; COLORING AGENTS; FLUOROMETRY; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MUSCLE FIBERS, SKELETAL; MYOBLASTS; NECROSIS; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTHESES AND IMPLANTS; PROTEASOME ENDOPEPTIDASE COMPLEX; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84880433654     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.005     Document Type: Article

References (66)

1. Bando Y., Katayama T., Aleshin A.N., Manabe T., Tohyama M. GRP94 reduces cell death in SH-SY5Y cells perturbated calcium homeostasis. Apoptosis 2004, 9:501-508.
2. Beyersmann D., Hartwig A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch. Toxicol. 2008, 82:493-512.
3. Boonyarom O., Inui K. Atrophy and hypertrophy of skeletal muscles: structural and functional aspects. Acta Physiol. (Oxf.) 2006, 188:77-89.
4. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., Hasselgren P.O., Frontera W.R., Lee J., Glass D.J., Shoelson S.E. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004, 119:285-298.
5. Cao P.R., Kim H.J., Lecker S.H. Ubiquitin-protein ligases in muscle wasting. Int. J. Biochem. Cell Biol. 2005, 37:2088-2097.
6. Catalani S., Rizzetti M.C., Padovani A., Apostoli P. Neurotoxicity of cobalt. Hum. Exp. Toxicol. 2011, 31:421-437.
7. 2-simulated hypoxia in skeletal muscle cell lines: role of free radicals in gene up-regulation and induction of apoptosis. Free Radic. Res. 2007, 421:391-401.
8. Dalle Donne I., Rossi R., Milzani A., Di Simplicio P., Colombo R. The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic. Biol. Med. 2001, 31:1624-1632.
9. De Rossi M., Bernasconi P., Baggi F., De Waal Malefit R., Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int. Immunol. 2000, 12:1329-1335.
10. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., Abbott D., Cuny G.D., Yuan C., Wagner G., Hedrick S.M., Gerber S.A., Lugovskoy A., Yuan J. Identification of RIP1 kinase as a specific cellular target of necrostatin. Nat. Chem. Biol. 2008, 4:313-321.
11. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29:313-326.
12. Eletto D., Dersh D., Argon Y. GRP94 in ER quality control and stress responses. Semin. Cell Dev. Biol. 2010, 21:479-485.
13. Escobedo J., Pucci A.M., Koh T.J. HSP25 protects skeletal muscle cells against oxidative stress. Free Radic. Biol. Med. 2004, 37:1455-1462.
14. Fanzani A., Zanola A., Rovetta F., Rossi S., Aleo M.F. Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signaling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol. Appl. Pharmacol. 2011, 250:312-321.
15. Fanzani A., Conraads V.M., Penna F., Martinet W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J. Cachex. Sarcopenia Muscle 2012, 3:163-179.
16. Foletta V.C., White L.J., Larsen A.E., Léger B., Russell A.P. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Eur. J. Physiol. 2011, 461:325-335.
17. Frasson M., Vitadello M., Brunati A.M., La Rocca N., Tibaldi E., Pinna L.A., Gorza L., Donella-Deana A. Grp94 is Tyr-phosphorylated by Fyn in the lumen of the endoplasmic reticulum and translocates to Golgi in differentiating myoblasts. Biochim. Biophys. Acta 2009, 1793:239-252.
18. Galluzzi L., Kepp O., Kroemer G. RIP kinases initiate programmed necrosis. J. Mol. Cell Biol. 2009, 1:8-10.
19. Glass D.J. Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:225-229.
20. Gorza L., Vitadello M. Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J. 2000, 14:461-475.
21. Harris R.M., Williams T.D., Hodges N.J., Waring R.H. Reactive oxygen species and oxidative DNA damage mediate the cytotoxicity of tungsten-nickel-cobalt alloys in vitro. Toxicol. Appl. Pharmacol. 2011, 250:19-28.
22. Hayot M., Rodriguez J., Vernus B., Carnac G., Jean E., Allen D., Goret L., Obert P., Candau R., Bonnieu A. Myostatin up-regulations associated with the skeletal muscle response to hypoxic stimuli. Mol. Cell. Endocrinol. 2011, 332:38-47.
23. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 2000, 1:489-495.
24. Hsu T.S., Yang P.M., Tsai J.S., Lin L.Y. Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicol. Appl. Pharmacol. 2009, 235:153-162.
25. Huk O.L., Catelas I., Mwale F., Antoniou J., Zukor D.J., Petit A. Induction of apoptosis and necrosis by metal ions in vitro. J. Arthroplasty 2004, 19:84-87.
26. Ikeda T., Takahashi K., Kabata T., Sakagoshi D., Tomita K., Yamada M. Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle Nerve 2010, 42:140-143.
27. Ito H., Kamei K., Iwamoto I., Inaguma Y., Kato K. Regulation of the levels of small heat-shock proteins during differentiation of C2C12 cells. Exp. Cell Res. 2001, 266:213-221.
28. Jomova Y., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
29. Karovic O., Tonazzini A., Rebola N., Edström E., Lövdahl C., Fredholm B.B., Darè E. Toxic effects of cobalt in primary cultures of mouse astrocytes. Similarities with hypoxia and role of HIF-1α. Biochem. Pharmacol. 2007, 73:694-708.
30. Keegan G.M., Learmonth I.D., Case C.P. A systematic comparison of the actual, potential, and theoretical health effects of cobalt and chromium exposures from industry and surgical implants. Crit. Rev. Toxicol. 2008, 38:645-674.
31. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., Ahn H.J., Ait-Mohamed O., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
32. Koseki T., Inohara N., Chen S., Núñez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5156-5160.
33. Li H., Malhotra S., Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J. Mol. Med. 2008, 86:1113-1126.
34. Lison D. Cobalt. Handbook on the toxicology of metals 2007, 511-528. Academic Press, Elsevier, Burlington. 3rd ed. G.F. Norberg, B.A. Fowler, M. Norberg, L.T. Friberg (Eds.).
35. Lison D., De Boeck M., Verougstraete V., Kirsch-Volders M. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup. Environ. Med. 2001, 58:619-625.
36. Maglara A.A., Vasilaki A., Jackson M.J., McArdle A. Damage to developing mouse skeletal muscle myotubes in culture: protective effect of heat shock proteins. J. Physiol. 2003, 548:837-846.
37. Mao X., Wong A.A., Crawford R.W. Cobalt toxicity-an emerging clinical problem in patients with metal-on-metal hip prostheses?. Med. J. Aust. 2011, 194:649-651.
38. McMahon D.K., Anderson P.A., Nassar R., Bunting J.B., Saba Z., Oakeley A.E., Malouf N.N. C2C12 cells: biophysical, biochemical, and immunocytochemical properties. Am. J. Physiol. 1994, 266:C1795-C1802.
39. Mizushima N., Yamamoto A., Matsui M., Yoshimori T., Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 2004, 15:1101-1111.
40. Nedachi T., Fujita H., Kanzaki M. Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1191-E1204.
41. Nishimura R.N., Sharp F.R. Heat shock proteins and neuromuscular disease. Muscle Nerve 2005, 32:693-709.
42. Oldenburg M., Wegner R., Baur X. Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J. Arthroplasty 2009, 24:825.e15-825.e20.
43. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197.
44. Pedersen B.K. Muscles and their myokines. J. Exp. Biol. 2011, 214:337-346.
45. Pelclova D., Sklensky M., Janicek P., Lach K. Severe cobalt intoxication following hip replacement revision: clinical features and outcome. Clin. Toxicol. (Phila.) 2012, 50:262-265.
46. Pizzo P., Scapin C., Vitadello M., Florean C., Gorza L. Grp94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells. J. Cell. Mol. Med. 2010, 14:970-981.
47. Richter K., Haslbeck M., Buchner J. The heat shock response: life on the verge of death. Mol. Cell 2010, 40:253-266.
48. Rizzetti M.C., Liberini P., Zarattini G., Catalani S., Pazzaglia U., Apostoli P., Padovani A. Loss of sight and sound. Could it be the hip? A case report. Lancet 2009, 373:1052.
49. Rovetta F., Stacchiotti A., Consiglio A., Cadei M., Grigolato P.G., Lavazza A., Rezzani R., Aleo M.F. ER signaling regulation drives the switch between autophagy and apoptosis in NRK-52E cells exposed to cisplatin. Exp. Cell Res. 2012, 318:238-250.
50. Salinthone S., Tyagi M., Gerthoffer W.T. Small heat shock proteins in smooth muscle. Pharmacol. Ther. 2008, 119:44-54.
51. Salucci S., Burattini S., Baldassarri V., Battistelli M., Canonico B., Valmori A., Papa S., Falcieri E. The peculiar apoptotic behavior of skeletal muscle cells. Histol. Histopathol. 2013, (Epub ahead of print).
52. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 2008, 23:160-170.
53. Sandri M. Autophagy in skeletal muscle. FEBS Lett. 2010, 584:1411-1416.
54. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. FoxO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
55. Steens W., von Foerster G., Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip - a case report. Acta Orthop. 2006, 77:830-832.
56. Tarricone E., Ghirardello A., Zampieri S., Rampudda M.L., Doria A., Gorza L. Cell stress response in skeletal muscle myofibers. Ann. N. Y. Acad. Sci. 2006, 10069:472-476.
57. 3) and metal (CoCr alloy) particles. Mutat. Res. 2010, 697:1-9.
58. Tsivitse S.K., Mylona E., Peterson J.M., Gunning W.T., Pizza F.X. Mechanical loading and injury induce human myotubes to release neutrophil chemoattractants. Am. J. Physiol. Cell Physiol. 2005, 288:C721-C729.
59. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 2010, 11:700-714.
60. Vanlangenakker N., Vanden Berghe T., Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ. 2012, 19:75-86.
61. Verma R., Xu X., Jaiswal M.K., Olsen C., Mears D., Caretti G., Galdzicki Z. In vitro profiling of epigenetic modifications underlying heavy metal toxicity of tungsten-alloy and its components. Toxicol. Appl. Pharmacol. 2011, 253:178-187.
62. Vertii A., Hakim C., Kotlyarov A., Gaestel M. Analysis of properties of small heat shock protein HSP25 in MAPK-activated protein kinase 2 (MK2)-deficient cells. J. Biol. Chem. 2006, 281:26966-26975.
63. Vitadello M., Penzo D., Petronilli V., Michieli G., Gomirato S., Menabò R., Di Lisa F., Gorza L. Overexpression of the stress protein GRP94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J. 2003, 17:923-925.
64. Wagatsuma A., Kotake N., Yamada S. Spatial and temporal expression of hypoxia-inducible factor-1a during myogenesis in vivo and in vitro. Mol. Cell. Biochem. 2010, 347:145-155.
65. Wu W., Liu P., Li J. Necroptosis: an emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 2012, 82:249-258.
66. Xiao R., Ferry A., Dupont-Versteegden E. Cell death-resistance of differentiated myocytes is associated with enhanced anti-apoptotic mechanisms compared to myoblasts. Apoptosis 2011, 16:221-234.